| 2992 |
2165: Activation of PPAR |
2169: Activation of Angiogenic cytokines |
Aug 20, 2023 |
Aug 20, 2023 |
1 AOP
|
| 1720 |
1507: Activation of PPARγ |
149: Increase, Inflammation |
Mar 18, 2018 |
Mar 18, 2018 |
None
|
| 1071 |
1028: Activation of specific nuclear receptors, PPAR-gamma activation |
1029: Increased, adipogenesis |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 1072 |
1028: Activation of specific nuclear receptors, PPAR-gamma activation |
1032: Increased, secretion of local growth factors |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 1609 |
1028: Activation of specific nuclear receptors, PPAR-gamma activation |
1449: increased adipogenesis |
Jul 24, 2017 |
Jul 24, 2017 |
1 AOP
|
| 319 |
288: Activation of specific nuclear receptors, Transcriptional change |
357: Cholestasis, Pathology |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 1354 |
1271: Activation of TGF-β signaling |
1272: Differentiation of Myofibroblast |
Feb 15, 2017 |
Feb 15, 2017 |
None
|
| 1355 |
1271: Activation of TGF-β signaling |
1273: Expression of Collagen |
Feb 15, 2017 |
Feb 15, 2017 |
None
|
| 1721 |
1271: Activation of TGF-β signaling |
149: Increase, Inflammation |
Mar 18, 2018 |
Mar 18, 2018 |
1 AOP
|
| 1723 |
1271: Activation of TGF-β signaling |
1457: EMT |
Mar 18, 2018 |
Mar 18, 2018 |
None
|
| 2600 |
1974: Activation of TP53 |
1365: Increase, Apoptosis |
Mar 9, 2022 |
Mar 9, 2022 |
None
|
| 2601 |
1974: Activation of TP53 |
1560: Altered differentiation |
Mar 17, 2022 |
Mar 17, 2022 |
None
|
| 2606 |
1974: Activation of TP53 |
1979: Premature differentiation |
Mar 21, 2022 |
Mar 21, 2022 |
1 AOP
|
| 3105 |
1974: Activation of TP53 |
1262: Apoptosis |
Jan 10, 2024 |
Jan 10, 2024 |
1 AOP
|
| 2986 |
2163: Activation Sema6A |
2164: Activation, Dll4-Notch pathway |
Aug 20, 2023 |
Aug 20, 2023 |
1 AOP
|
| 1375 |
1288: Activation, 3-hydroxy-3-methylglutaryl-CoA reductase gene |
1289: Perturbation of cholesterol |
Feb 15, 2017 |
Feb 15, 2017 |
1 AOP
|
| 1438 |
1336: Activation, 5-HT2A |
1337: Activate, PLC |
Apr 14, 2017 |
Apr 14, 2017 |
2 AOPs
|
| 750 |
9: Activation, 5HT2c |
294: N/A, Unknown |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 18 |
18: Activation, AhR |
17: Altered expression of AHR/ARNT pathway-dependent genes |
Nov 29, 2016 |
Dec 3, 2016 |
None
|
| 19 |
18: Activation, AhR |
80: Up Regulation, CYP1A1 |
Nov 29, 2016 |
Dec 3, 2016 |
2 AOPs
|
| 473 |
18: Activation, AhR |
451: Inhibition, Mitochondrial fatty acid beta-oxidation |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 495 |
18: Activation, AhR |
54: Up Regulation, CD36 |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 496 |
18: Activation, AhR |
465: Increased, FA Influx |
Nov 29, 2016 |
Dec 3, 2016 |
None
|
| 499 |
18: Activation, AhR |
216: Decreased, PCK1 expression (control point for glycolysis/gluconeogenesis pathway) |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 506 |
18: Activation, AhR |
466: Up Regulation, LDLR (low density lipoprotein receptor) |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|